Review Article
Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
Table 1
Cytokines used as different types of lung cancer biomarkers.
| Cytokine | Sample | Current purpose as a biomarker | Current well-known function in lung cancer |
| IL-6 | Blood, BALF, and pleural effusion | Diagnostic, prognostic, and predicting the treatment response | Prooncogenic | IL-8 | Blood, BALF, and sputum | Diagnostic and prognostic | Prooncogenic | VEGF | Blood, BALF, sputum, pleural effusion, and tissue | Diagnostic and prognostic | Prooncogenic | TNF-α | Blood | Predicting the treatment response | Prooncogenic and antitumor, depending on the context | IL-2 | Blood | Prognostic and predicting the treatment response | Not yet determined | IL-18 | Blood, BALF, and sputum | Diagnostic | Not yet determined | IL-10 | Blood | Diagnostic | Prooncogenic and antitumor, depending on the context | IL-13 | Blood | Diagnostic | Not yet determined | IL-22 | Blood | Diagnostic and prognostic | Prooncogenic | IFN-γ | Blood | Diagnostic and prognostic | Not yet determined | IL-32 | Tissue | Prognostic | Prooncogenic | IL-37 | Tissue | Prognostic | Antitumor |
|
|